Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-16

Clinical Trial Update: Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome [Phase 4]

View source ↗

Summary

Phase 4 randomized trial update comparing gabapentin and gabapentin enacarbil for Restless Leg Syndrome; study TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • gabapentin enacarbil (gabapentin enacarbil)

Snippet

Sponsor: Theresa Zesiewicz, MD | Conditions: Restless Leg Syndrome | Phase 4 | Status: TERMINATED